Do breathing exercises improve symptoms of allergic rhinitis?

Breathing Exercises as Adjunctive Therapy for Allergic Rhinitis

Yes, breathing exercises should be recommended as an adjunctive treatment to intranasal corticosteroids for patients with allergic rhinitis, as they provide clinically meaningful symptom reduction and improved quality of life without adverse effects.

Primary Recommendation

The most recent ARIA guidelines 1 do not specifically address breathing exercises, focusing instead on pharmacologic comparisons between antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists. However, the absence of breathing exercises from guideline recommendations reflects the limited evidence available at the time of publication (2016-2017), not a recommendation against their use.

Evidence Supporting Breathing Exercises

Nasal Breathing Exercises with Pharmacotherapy

The strongest evidence comes from a randomized controlled trial demonstrating that nasal breathing exercises combined with fluticasone propionate nasal spray produced significantly greater symptom reduction than fluticasone alone (mean total nasal symptom score: 2.68 vs 3.83, P < 0.05) 2. This study showed:

• Both individual and overall symptoms improved more with the combination approach
• The intervention is simple, cost-effective, and enhances patient satisfaction
• No adverse events were reported

Nasal Rehabilitation Programs

The most recent evidence (2026) demonstrates that structured nasal rehabilitation programs are feasible, safe, and effective 3:

• 92.5% adherence rate among patients
• Significant improvements in Total Nasal Symptom Score (mean improvement: 2.00 points)
• Enhanced disease-specific quality of life (Rhinoconjunctivitis Quality of Life Questionnaire improved by 0.94 points)
• Zero adverse events reported
• Benefits achieved without pharmacologic treatment during the 5-week intervention

Yoga-Based Breathing Techniques

Hatha yoga breathing exercises demonstrated objective improvements in airway function 4:

• Significant reduction in total nasal airway resistance at 150 Pa
• Improved forced expiratory volume (FEV1) in allergic rhinitis patients
• Significant improvements in both physical and mental component scores on quality of life assessments
• Reduced SNOT questionnaire scores indicating better symptom control

Clinical Algorithm for Implementation

For patients with moderate-to-severe allergic rhinitis:

1. First-line treatment: Initiate intranasal corticosteroid (per ARIA guidelines 1)

2. Add nasal breathing exercises immediately as adjunctive therapy:

   • Instruct patients in structured nasal breathing techniques
   • Recommend daily practice for at least 5 weeks
   • Expected adherence rates exceed 90% based on pilot data 3

3. Monitor response at 4-5 weeks:

   • Assess symptom scores and quality of life
   • Expect clinically meaningful improvements in nasal congestion, itching, sneezing, and rhinorrhea

4. Consider additional pharmacotherapy only if symptoms remain inadequately controlled after combined intranasal corticosteroid + breathing exercise approach

Important Caveats

• All research evidence comes from studies with small sample sizes (35-60 participants), though results are consistently positive across multiple trials
• The ARIA guidelines 1 note that recommendations apply primarily to moderate-to-severe allergic rhinitis; patients with mild disease often self-manage successfully
• Breathing exercises should complement, not replace, evidence-based pharmacotherapy in patients with moderate-to-severe disease
• The 2026 nasal rehabilitation study 3 demonstrated efficacy as monotherapy, but this approach requires further validation before recommending discontinuation of standard medications

Practical Advantages

Breathing exercises offer several clinical benefits:

• No adverse effects reported across all studies
• Cost-effective intervention requiring no additional medications
• High patient adherence (>90%) when properly instructed
• Objective improvements in nasal airflow and airway resistance, not just subjective symptom relief
• Quality of life benefits extend beyond nasal symptoms to overall physical and mental well-being

The evidence consistently supports incorporating breathing exercises into the treatment algorithm for allergic rhinitis, particularly when combined with intranasal corticosteroids as recommended by ARIA guidelines 1, 3, 2.